MedTrace Logo

Efficacy of Tailored Bowel Preparation Strategy: A Randomized Controlled Study

NCT03765216 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2018-12-05

No results posted yet for this study

Summary

About 30% of patients were reported to suffer inadequate bowel preparation. So, it is desirable to prescribe personalized regimen according to patient's personal characteristics.

Conditions

  • Bowel Preparation
  • Colonoscopy

Interventions

DRUG

2L Polyethylene Glycol (PEG)

Participants in Group A and Low risk patients in group B are given standard regimen: 2 L Polyethylene Glycol (PEG) regimen

DRUG

4L Polyethylene Glycol (PEG)

High risk patients in Group B will receive 4 L Polyethylene Glycol (PEG) regimen

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Li Yanqing, PhD,MD · Qilu Hospital, Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-02-28
Completion
2019-03-15

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03765216 on ClinicalTrials.gov